Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
Gepubliceerd in:
2015 | OriginalPaper | Hoofdstuk
23 Economische evaluaties van implementatiestrategieën
Auteurs : prof.dr. Hans Severens, dr. Ties Hoomans, dr. Eddy Adang, prof.dr. Michel Wensing
Gepubliceerd in: Implementatie
Uitgeverij: Bohn Stafleu van Loghum
share
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Samenvatting
-
Economische evaluaties van implementatieprogramma’s worden in toenemende mate uitgevoerd, maar zijn nog steeds relatief zeldzaam.
-
Economische evaluaties van implementatiestrategieën zijn gebaseerd op een expliciete vergelijking van alternatieve manieren om gewenste veranderingen in de zorg in te voeren. In tegenstelling tot economische evaluaties van patiëntgebonden interventies kunnen bij economische evaluaties van implementatiestrategieën zowel proces- als patiëntuitkomsten als effectiviteitsmaten worden gebruikt.
-
Economische evaluaties van implementatiestrategieën zijn het meest zinvol als de kosteneffectiviteit van het gewenste professionele handelen of het zorgproces bekend en acceptabel is. Dan kan de kosteneffectiviteit van het volledig traject – van implementatie tot en met de uiteindelijke patiëntuitkomst – (modelmatig) worden vastgesteld.
-
Bij verbeterprojecten en grootschalige implementatieprojecten is in de regel geen sprake van een volwaardige economische evaluatie, maar de kosten en verandering in de zorg worden afzonderlijk beschreven.
Log in om toegang te krijgen
Literatuur
go back to reference Adang EMM, Wensing M. Economic barriers to implementation of innovations in healthcare: Is the long run-short run efficiency discrepancy a paradox? Health Policy 2008;2-3:256-62.
Adang EMM, Wensing M. Economic barriers to implementation of innovations in healthcare: Is the long run-short run efficiency discrepancy a paradox? Health Policy 2008;2-3:256-62.
go back to reference Hoomans T, et al. Value for money in changing clinical practice: should decisions about guidelines and implementation strategies be made sequentially or simultaneously? Med Decis Making 2009;29(2):207-16.PubMed
Hoomans T, et al. Value for money in changing clinical practice: should decisions about guidelines and implementation strategies be made sequentially or simultaneously? Med Decis Making 2009;29(2):207-16.PubMed
go back to reference Mason J, et al. When is it cost-effective to change the behaviour of health professionals? JAMA 2001;286: 2988-92.CrossRefPubMed
Mason J, et al. When is it cost-effective to change the behaviour of health professionals? JAMA 2001;286: 2988-92.CrossRefPubMed
go back to reference Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care 2003;12:366-71.CrossRefPubMedPubMedCentral
Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care 2003;12:366-71.CrossRefPubMedPubMedCentral
go back to reference Adang E, Voordijk L, Wilt GJ van der, Ament A. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Health Policy 2005;74:146-56.CrossRefPubMed
Adang E, Voordijk L, Wilt GJ van der, Ament A. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Health Policy 2005;74:146-56.CrossRefPubMed
go back to reference Adang EMM, Wensing M. Economic barriers to implementation of innovations in healthcare: Is the long run-short run efficiency discrepancy a paradox? Health Policy 2008;2-3:256-62.
Adang EMM, Wensing M. Economic barriers to implementation of innovations in healthcare: Is the long run-short run efficiency discrepancy a paradox? Health Policy 2008;2-3:256-62.
go back to reference Anoniem. Richtlijnen voor farmaco-economisch onderzoek, geactualiseerde versie. Volgnummer 25001605. Diemen: College voor zorgverzekeringen, 2006.
Anoniem. Richtlijnen voor farmaco-economisch onderzoek, geactualiseerde versie. Volgnummer 25001605. Diemen: College voor zorgverzekeringen, 2006.
go back to reference Black NA. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-8.CrossRefPubMedPubMedCentral
Black NA. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-8.CrossRefPubMedPubMedCentral
go back to reference Brennan A, Akehurst R. Modelling in economic evaluation: What is it place?; What is its value? PharmacoEconomics 2000;17:445-59.CrossRefPubMed
Brennan A, Akehurst R. Modelling in economic evaluation: What is it place?; What is its value? PharmacoEconomics 2000;17:445-59.CrossRefPubMed
go back to reference Briggs AH, Sculpher M, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics 1994;3:95-104.CrossRefPubMed
Briggs AH, Sculpher M, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics 1994;3:95-104.CrossRefPubMed
go back to reference Buxton MJ, Drummond MF, Hout BA van, et al. Modelling in economic evalution: an unavoidable fact of life. Health Economics 1997;6:217-27.CrossRefPubMed
Buxton MJ, Drummond MF, Hout BA van, et al. Modelling in economic evalution: an unavoidable fact of life. Health Economics 1997;6:217-27.CrossRefPubMed
go back to reference Doubilet PM, Weinstein MC, McNeil BJ. Use and misuse of the term ‘cost effective’ in medicine. N Engl J Med 1986;314:253-5.CrossRefPubMed
Doubilet PM, Weinstein MC, McNeil BJ. Use and misuse of the term ‘cost effective’ in medicine. N Engl J Med 1986;314:253-5.CrossRefPubMed
go back to reference Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford Medical Publications, 2005.
Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford Medical Publications, 2005.
go back to reference Eichler HG, Kong SX, Gerth WC, et al. Use of cost-effectiveness analysis in healthcare resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 2004;7(5):518-28.CrossRefPubMed
Eichler HG, Kong SX, Gerth WC, et al. Use of cost-effectiveness analysis in healthcare resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 2004;7(5):518-28.CrossRefPubMed
go back to reference Frijling BD, Hulscher MEJL, Wouden JC van der. Optimaliseren van de zorg voor patiënten met cardiovasculaire aandoeningen of risicofactoren in de huisarts(en)praktijk. Eindrapportage CARPE-project. Nijmegen: WOK/EUR, 2001.
Frijling BD, Hulscher MEJL, Wouden JC van der. Optimaliseren van de zorg voor patiënten met cardiovasculaire aandoeningen of risicofactoren in de huisarts(en)praktijk. Eindrapportage CARPE-project. Nijmegen: WOK/EUR, 2001.
go back to reference Grimshaw GM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.CrossRefPubMed
Grimshaw GM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.CrossRefPubMed
go back to reference Grimshaw GM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies, Health Technol Assess 2004;8:6.CrossRef
Grimshaw GM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies, Health Technol Assess 2004;8:6.CrossRef
go back to reference Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie. Diemen: College voor zorgverzekeringen, 2010.
Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie. Diemen: College voor zorgverzekeringen, 2010.
go back to reference Harmsen M, Adang EM, Wolters RJ, et al. Management of childhood urinary tract infections: an economic modeling study. Value Health 2009;12(4):466-72.CrossRefPubMed
Harmsen M, Adang EM, Wolters RJ, et al. Management of childhood urinary tract infections: an economic modeling study. Value Health 2009;12(4):466-72.CrossRefPubMed
go back to reference Hoomans T, Ament AJ, Evers SM, et al. Implementing guidelines into clinical practice: what is the value? J Eval Clin Pract 2010 [Epub ahead of print].
Hoomans T, Ament AJ, Evers SM, et al. Implementing guidelines into clinical practice: what is the value? J Eval Clin Pract 2010 [Epub ahead of print].
go back to reference Hoomans T, Abrams KR, Ament AJHA, et al. Modelling the value for money of changing clinical practice change: a stochastic application in diabetes care. Med Care 2009;47(10):1053-61.CrossRefPubMed
Hoomans T, Abrams KR, Ament AJHA, et al. Modelling the value for money of changing clinical practice change: a stochastic application in diabetes care. Med Care 2009;47(10):1053-61.CrossRefPubMed
go back to reference Hoomans T, Evers SMAA, Ament AJHA, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health 2007;10;305-16.CrossRefPubMed
Hoomans T, Evers SMAA, Ament AJHA, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health 2007;10;305-16.CrossRefPubMed
go back to reference Kaner EFS, Lock CA, McAvoy BR, et al. A RCT of three training and support strategies to encourage implementation of screening and brief alcohol intervention by general practitioners. Br J Gen Pract 1999;49:699-703.PubMedPubMedCentral
Kaner EFS, Lock CA, McAvoy BR, et al. A RCT of three training and support strategies to encourage implementation of screening and brief alcohol intervention by general practitioners. Br J Gen Pract 1999;49:699-703.PubMedPubMedCentral
go back to reference Koopmanschap MA, Rutten FFH. Berekening van kosten van zorg; vaak onderschat in economische evaluaties. TSG 1998;76:83-8.
Koopmanschap MA, Rutten FFH. Berekening van kosten van zorg; vaak onderschat in economische evaluaties. TSG 1998;76:83-8.
go back to reference Kroese M, Severens JL, Schulpen G, Bessems M, Nijhuis F, Landewé R. Specialised rheumatology nurse substitutes for rheumatologist in the diagnostic process of fibromyalgia: a cost consequence analysis alongside a randomised controlled trial. J Rheumatol 2011 (accepted for publication).
Kroese M, Severens JL, Schulpen G, Bessems M, Nijhuis F, Landewé R. Specialised rheumatology nurse substitutes for rheumatologist in the diagnostic process of fibromyalgia: a cost consequence analysis alongside a randomised controlled trial. J Rheumatol 2011 (accepted for publication).
go back to reference Laupacis A, Feeny DH, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clininal and economic evaluations. CMAJ 1992;146:473-81.PubMedPubMedCentral
Laupacis A, Feeny DH, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clininal and economic evaluations. CMAJ 1992;146:473-81.PubMedPubMedCentral
go back to reference Mason, J et al. When is it cost-effective to change the behaviour of health professionals? JAMA 2001;286:2988-92.CrossRefPubMed
Mason, J et al. When is it cost-effective to change the behaviour of health professionals? JAMA 2001;286:2988-92.CrossRefPubMed
go back to reference Mason J, Wood J, Freemantle N. Designing evaluations of interventions to change professional practice. J Health Serv Res Policy 1999;4:106-11.PubMed
Mason J, Wood J, Freemantle N. Designing evaluations of interventions to change professional practice. J Health Serv Res Policy 1999;4:106-11.PubMed
go back to reference Mauskopf JA, Paul JE, Grant DM, et al. The role of cost-consequence analysis in health care decision making. PharmacoEconomics 1998;13:277-88.CrossRefPubMed
Mauskopf JA, Paul JE, Grant DM, et al. The role of cost-consequence analysis in health care decision making. PharmacoEconomics 1998;13:277-88.CrossRefPubMed
go back to reference McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of costy-benefit analysis in health care. PharmacoEconomics 1999;15:357-67.CrossRefPubMed
McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of costy-benefit analysis in health care. PharmacoEconomics 1999;15:357-67.CrossRefPubMed
go back to reference O’Brien BJ. Economic evaluation of pharmaceuticals: Frankenstein’s monster or vampire of trails? Medical Care 1996;34(Supplement):DS99-DS108.
O’Brien BJ. Economic evaluation of pharmaceuticals: Frankenstein’s monster or vampire of trails? Medical Care 1996;34(Supplement):DS99-DS108.
go back to reference O’Brien JA, Jacobs LM, Pierce D Clinical practice guidelines and the cost of care. Int J Technol Assess Health Care 2000;16:1077-91.CrossRefPubMed
O’Brien JA, Jacobs LM, Pierce D Clinical practice guidelines and the cost of care. Int J Technol Assess Health Care 2000;16:1077-91.CrossRefPubMed
go back to reference Richardson G. Cost-effectiveness of implementing new guidelines for treatment of hypertension in general practice. Br J Gen Pract 2004;54:765-71.PubMedPubMedCentral
Richardson G. Cost-effectiveness of implementing new guidelines for treatment of hypertension in general practice. Br J Gen Pract 2004;54:765-71.PubMedPubMedCentral
go back to reference Riteco JA, Heij LJM de, Luijn JCF van, et al. Richtlijnen voor farmaco-economisch onderzoek. Amstelveen: College voor zorgverzekeringen (CVZ), 1999.
Riteco JA, Heij LJM de, Luijn JCF van, et al. Richtlijnen voor farmaco-economisch onderzoek. Amstelveen: College voor zorgverzekeringen (CVZ), 1999.
go back to reference Robinson MB, Thompson E, Black NA. Why is the evaluation of the cost-effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction. Qual Health Care 1998;7:19-26.PubMed
Robinson MB, Thompson E, Black NA. Why is the evaluation of the cost-effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction. Qual Health Care 1998;7:19-26.PubMed
go back to reference Scheeres K, Wensing M, Bleijenberg G, Severens J. Implementing cognitive behaviour therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res 2008;8:175.CrossRefPubMedPubMedCentral
Scheeres K, Wensing M, Bleijenberg G, Severens J. Implementing cognitive behaviour therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res 2008;8:175.CrossRefPubMedPubMedCentral
go back to reference Schermer, T.R., et al., Randomized controlled economic evaluation of astma self-management in primary health care. Am J Resp Crit Care Med 2002;166: 1062-72.CrossRefPubMed
Schermer, T.R., et al., Randomized controlled economic evaluation of astma self-management in primary health care. Am J Resp Crit Care Med 2002;166: 1062-72.CrossRefPubMed
go back to reference Sculpher M. Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines. Fam Pract 2000;17: S26-S31.CrossRefPubMed
Sculpher M. Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines. Fam Pract 2000;17: S26-S31.CrossRefPubMed
go back to reference Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care 2003;12: 366-71.CrossRefPubMedPubMedCentral
Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care 2003;12: 366-71.CrossRefPubMedPubMedCentral
go back to reference Tulder MW van, Koes BW, Bouter LM. A cost-of-illness study of back pain in The Netherlands. Pain1995;62:233-40.CrossRefPubMed
Tulder MW van, Koes BW, Bouter LM. A cost-of-illness study of back pain in The Netherlands. Pain1995;62:233-40.CrossRefPubMed
go back to reference Vale L, Thomas R, MacLennan G, Grimshaw J. Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ 2007;8(2):111-21.CrossRefPubMed
Vale L, Thomas R, MacLennan G, Grimshaw J. Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ 2007;8(2):111-21.CrossRefPubMed
go back to reference Verstappen WH, Merode F van, Grimshaw J, et al. Comparing cost effects of two quality strategies to improve test ordering in primary care: a randomized trial. Int J Qual Health Care 2004;16(5):391-8.CrossRefPubMed
Verstappen WH, Merode F van, Grimshaw J, et al. Comparing cost effects of two quality strategies to improve test ordering in primary care: a randomized trial. Int J Qual Health Care 2004;16(5):391-8.CrossRefPubMed
go back to reference Weinstein WC, O’Brien BJ, Hornberger J. et al. Principles of good practice of decision analytic modelling in health care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health 2003;6(1):9-17.CrossRefPubMed
Weinstein WC, O’Brien BJ, Hornberger J. et al. Principles of good practice of decision analytic modelling in health care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health 2003;6(1):9-17.CrossRefPubMed
go back to reference Wensing M, Weijden T van der, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998;48:991-7.PubMedPubMedCentral
Wensing M, Weijden T van der, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998;48:991-7.PubMedPubMedCentral
go back to reference Wetering G van de, Woertman W, Adang EMM. A model to correct for short run inefficiencies in economic evaluations in health care. Health Economics 2011;DOI:10.1002/hec.1705.
Wetering G van de, Woertman W, Adang EMM. A model to correct for short run inefficiencies in economic evaluations in health care. Health Economics 2011;DOI:10.1002/hec.1705.
Metagegevens
- Titel
- 23 Economische evaluaties van implementatiestrategieën
- Auteurs
-
prof.dr. Hans Severens
dr. Ties Hoomans
dr. Eddy Adang
prof.dr. Michel Wensing
- Copyright
- 2015
- Uitgeverij
- Bohn Stafleu van Loghum
- Boek
-
Implementatie
Print ISBN: 978-90-368-1076-0
Elektronisch ISBN: 978-90-368-1077-7
Copyright: 2015
- DOI
- https://doi.org/10.1007/978-90-368-1077-7_23